| Zacks Company Profile for Nanovibronix, Inc. (NAOV : NSDQ) |
|
|
| |
| • Company Description |
| NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.
Number of Employees: 31 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.96 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 3,132,842 shares |
| Shares Outstanding: 2.58 (millions) |
| Market Capitalization: $2.48 (millions) |
| Beta: 1.71 |
| 52 Week High: $10.63 |
| 52 Week Low: $0.67 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-16.63% |
-19.49% |
| 12 Week |
-86.61% |
-88.70% |
| Year To Date |
-85.23% |
-86.15% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Brian Murphy - Chief Executive Officer and Director
Christopher Fashek - Chairman of the Board
Stephen Brown - Chief Financial Officer
Martin Goldstein - Director
Doron Besser - Director
|
|
Peer Information
Nanovibronix, Inc. (ABMD)
Nanovibronix, Inc. (DMDS)
Nanovibronix, Inc. (CPWY.)
Nanovibronix, Inc. (EQUR)
Nanovibronix, Inc. (ECIA)
Nanovibronix, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 63008J702
SIC: 3842
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
|
|
Share - Related Items
Shares Outstanding: 2.58
Most Recent Split Date: 3.00 (0.09:1)
Beta: 1.71
Market Capitalization: $2.48 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/13/25 |
|
|
|
| |
